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The burden of Salmonella Typhi shedding in stool and its contribution to transmission in 
endemic settings is unknown. During passive surveillance S. Typhi shedding was seen during 
convalescence in 332 bacteremic typhoid patients although none persisted at one-year 
follow-up. Anti-Vi-IgG titres were measured in age-stratified cohort of serosurveillance 
participants. Systematic stool sampling of 303 participants with high anti-Vi-IgG titres 
identified one asymptomatic carrier shedding. These findings suggest ongoing S. Typhi 
transmission in this setting is more likely to occur from acute convalescent cases although 
better approaches are needed to identify true chronic carriers in the community to enable 
typhoid elimination.  
































































































Humans are the only natural host and reservoir of Salmonella enterica serotype Typhi (S. 
Typhi), the causative organism of typhoid fever. The multiplication of  S. Typhi  outside the 
human host  is not robust, although some ability to survive in the environment for an 
extended time is theoretically required for transmission [1]. Typhoid is transmitted by 
consumption of food and water contaminated by bacteria shed by acute cases or chronic 
carriers [2]. After recovery from acute disease, approximately 2–5% patients fail to clear the 
infections [3, 4]. To maintain this carriage state, S. Typhi colonizes the gallbladder to form 
dense bacterial biofilms on gallstones and other surfaces from where organisms are shed 
intermittently and are excreted in stool [5]. 
While implementing preventive measures such as vaccination will lead to elimination of 
typhoid from endemic regions, additional interventions are needed to stop the ongoing 
transmission of S. Typhi from chronic carriers. This requires tools to accurately identify and 
appropriately treat individuals shedding S. Typhi. Detection of chronic carriers is challenging, 
however, as the majority are asymptomatic and up to 25% do not recall symptoms or an 
episode compatible with acute typhoid fever [4]. Microbiological culture of bile, gallstones, 
or gallbladder tissue from individuals undergoing cholecystectomy are gold-standard 
approaches to the accurate, but often coincidental, diagnosis of chronic carriage. Methods 
to obtain this material (surgical or string-test) are not feasible to collect at large, community 
or population scales. Culture of serially collected stool specimens is not easy to perform and 
may only have a limited increase in diagnostic yield [6]. Some studies have demonstrated 
that high IgG isotype antibody titres to the Vi (virulence) capsule of S. Typhi (anti-Vi-IgG) can 






























































































outbreak settings, although this approach has not been evaluated prospectively at the 
population level [5]. 
The rate of stool shedding and contribution to transmission from short-term, convalescent 
shedding and longer-term, temporary or chronic carriage is unknown in endemic settings. 
Bangladesh is an area of high endemicity for typhoid fever and therefore a well-placed 
setting to explore these unknowns. A comprehensive population-based study was carried 
out in a densely-populated area of Dhaka, Bangladesh, under the umbrella of the Strategic 
Typhoid Alliance across Africa and Asia (STRATAA) to detect the occurrence and duration of 
S. Typhi shedding from both acutely infected patients and from asymptomatic chronic 
carriers detected by serosurveillance.  
 Methods: 
Enumeration of population and passive surveillance 
Passive surveillance for acute typhoid fever was performed in wards 3 and 5 of the Mirpur 
area in Dhaka city, Bangladesh [7]. A baseline census and 6-monthly updates were carried 
out to enumerate the population and to collect baseline characteristics.  
In passive surveillance, patients presenting with history of fever for ≥72 hours or axillary 
temperature ≥38.5oC were enrolled. In a subsequent amendment to the study protocol the 
inclusion criteria were changed to include fever ≥48 hours or axillary temperature ≥38.0oC. 
At enrollment (day 0), blood and stool specimens were collected for culture to confirm 
acute typhoid cases. Study participants diagnosed with typhoid by blood culture and whose 
households were enrolled in the census survey were identified as ‘index case’. Index cases 
were treated with antibiotics determined by bacterial susceptibility. Stool specimens were 






























































































collected in those found to be shedding at these timepoints one year following study 
enrollment. The participants who were blood culture negative but stool culture positive, 
were undergone the same schedule of follow up and household contact screening. They 
were also identified as ‘index case’ if their households were enrolled in the census. 
Immediately after confirming the index cases, all household members were invited to 
participate in the study and stool specimens were collected on days 0 and 30 from the 
household contacts who have provided consent. A further stool specimen was collected on 
day 180 when culture results were positive at day 0 and/or day 30. A follow-up stool 
specimen was recommended at 1 year depending on the culture result at day 180 in order 
to confirm continued shedding.  
 
 Serosurvey 
Age stratified (0-4 years, 5-9 years, 10-14 years and >14 years) apparently healthy 
participants were randomly selected from the census population and enrolled to a 
serosurveillance component. Recruitment of selected participants and collection of 
specimens was carried out throughout the year, in 3 monthly blocks. Blood specimens were 
collected from the participants on days 0 and 90 after enrollment and anti-Vi-IgG responses 
were measured. A Vi-IgG threshold value was calculated using the first 1000 specimens 
collected, based on the 97
th
 centile of titres measured in participants <15 years, or the 95
th
 
centile of participants ≥15 years of age. This provided thresholds of 96.2 EU/ml and 57.1 
EU/ml anti-Vi-IgG, respectively. 
Participants with anti-Vi-IgG titres over these thresholds (seropositive) were followed-up on 






























































































follow-up of those participants identified as possible asymptomatic carriers was performed 
(defined as a seropositive participant with stool culture positive for S. Typhi). 
Laboratory procedure 
Informed written consent was obtained from guardians of young participants (1–17 years) 
while adult participants (18–59 years) provided their own consent. Stool cultures were 
performed at the icddr,b laboratory. Inoculation and emulsification of stool in Selenite F 
broth media for parallel enrichment and direct inoculation to MacConkey and Salmonella-
Shigella selective agar plates was performed. Incubation of all cultures were carried out at 
37°C for 18-24 hours. Colonies of S. Typhi were identified by phenotypic morphology, 
standard biochemical tests and slide agglutination to Salmonella-specific antisera. 
Antimicrobial susceptibility testing was performed using standard disk diffusion methods 
[8]. 
Plasma was separated from participant blood by centrifugation and anti-Vi-IgG titres were 
measured using a commercial assay (the VaccZyme ELISA, The Binding Site, Birmingham, UK) 
following the manufacturer’s guidelines. [9] 
Treatment of chronic carriers 
Antibiotic treatment was recommended for index cases and their household contacts as per 
a pre-agreed management plan, if shedding continued for up to 1 year after enrollment. 
Similarly, antibiotic treatment was also planned for any asymptomatic chronic carriers 
detected through serosurveillance [7]. After completion of antibiotic therapy 3 consecutive 
































































































Chi-Square test and Mann Whitney U Test were used to evaluate the differences among 
groups  




The total number of individuals included in the study census was 111,695, among whom 
4,509 patients met the inclusion criteria and were enrolled to the passive surveillance study 
between August 2016 and January 2019. Of these, 332/4,509 (7%) were confirmed as 
typhoid cases by blood culture and formed the index case population and 109/332 (33%) 
were also stool culture positive at enrollment (day 0).  In total, stool specimens were 
collected from 4,216 of the 4509 participants enrollment, of which 33/4216 (0.8%) patients 
were stool culture positive but negative by blood culture.  
Among the 332 blood culture-confirmed index cases, stool culture was again positive for 
15/281 (5%) and 1/270 (0.4%) patients on days 30 and 180 respectively (Table 1). None of 
these patients was found to shed S. Typhi one year later. In patients with only positive stool 
cultures,  1 out of 9  was positive on day 30 and none were positive at later time points.  
For household contacts of blood-culture confirmed index cases (n=332), 530 household 
contacts from 217 households (2.4 contacts per household) were enrolled in the study. 
Stool specimens were obtained from 530 and 466 household contacts on days 0 and 30 and 
tested for culture. The median age of household contacts was 29 years (range from 5 






























































































5/530 (0.9%) and 4/466 (0.7%) participants were S. Typhi positive in stool on days 0 and 30, 
respectively (Table 2). No shedding was revealed on day 180 among seven contacts from 
whom stool specimens were obtained and no stool was therefore collected at one year.  
Of 332 blood culture-confirmed index cases, 16 patients from 8 households (2 patients per 
household) had typhoid fever episode at the same time within their households. Among 
them, one pair of index cases of the same household were also shedding the bacterium at 
the same time. 
For stool culture-only positive index cases (n=33), 9 household contacts from 5 different 
households (1.8 contacts per household) were enrolled in the study. The median age of the 
contacts was 29 years (range from 8 years to 48 years) and the male-female ratio was 1:2. 
Stool specimens were collected from them and tested for culture on days 0 and 30 and none 
were found to shed S. Typhi at these  time points (Table 2). 
Exploratory analyses of baseline characteristics (age, temperature and duration of fever) 
demonstrated no significant differences between patients who were positive for both blood 
and stool culture and patients who were positive only by blood culture. However, the 
proportion of prior antibiotic usage for the both blood and stool culture positive patients 
(24/109 [22%]) was significantly lower (P=<0.05) than the patients that were blood culture 
































































































Paired blood specimens were collected from 8,261 and 7,043 participants days 0 and 90 
respectively. High anti-Vi-IgG titres were measured in 303 participants on days 0 and/or 90, 
among whom 136 had persistently high Vi for both time points. Two stool specimens 48 
hours apart were collected from 192 of 303 participants on day 180.  
Only one female aged 36 years was S. Typhi positive by stool culture and therefore 
identified as an asymptomatic chronic (probable) carrier and was treated with ciprofloxacin 
(750 mg BD for 28 days). No S. Typhi shedding was detected in 3 consecutive stool 
specimens collected after completion of antibiotic treatment. Ultrasonography of the 
hepatobiliary system revealed gallstones and further advice was provided regarding 
consideration for elective cholecystectomy.  
Discussion: 
The study results demonstrate the high proportion of typhoid fever patients who shed S. 
Typhi in their stool during the acute stages of typhoid fever. This is a potential high-risk 
period for human-to-human transmission to occur given the likely debilitation of the patient 
and their care needs. Those at greatest risk would include household members and care-
givers. In contrast, very low levels of continued shedding was seen during treatment and 
convalescence stages, likely a reflection of high levels of effectiveness of modern 
antimicrobial therapy. No study participants developed continued shedding into the chronic 
carriage stage. Although no difference was found in duration of fever for the patients of 
blood and stool culture positive and the patients of only blood culture positive, but an 
association of early S. Typhi shedding and development of typhoid fever has also been 






























































































antibiotic intake was observed in more blood culture positive patients who were also 
shedding S. Typhi than the only blood culture positive patients. Similarly, after initiation of 
antibiotic in human challenge model no shedding was seen [10]. 
Participants who were stool culture positive but blood culture negative, indicating either 
recent infection with short term shedding or a falsely negative blood culture, have the 
potential to impact for continued maintenance of the organism within human population. 
Hence, they were followed-up in the same way of blood culture positive index cases and 
household contact screening. However, stool specimen collection and retesting on day 30 
was possible for 9 out of 33 (27%) stool culture positive index cases and one of which was 
positive for S. Typhi. Therefore, it is difficult to make an inference from this study result 
regarding the rates and duration of bacterial shedding and the impact of only stool culture 
positive patients in spreading the organism. 
The household contact study revealed that some household members of the acute patients 
shed S. Typhi in the absence of typhoid fever symptoms and during the active disease period 
of the index cases. In addition, some blood culture positive index cases had typhoid fever 
episode within a household at the same time among whom two index cases also had 
bacterial shedding in their stool. In support of our findings, many epidemiological studies 
have reported that S. Typhi is transmitted from convalescent carriers to close contacts of 
patients within their household [11, 12].  
One person was confirmed as an asymptomatic carrier identified by serosurveillance. 
Increased age, female gender, gallbladder disease are risk factors for developing chronic 































































































There are several important points to consider in interpreting the low rates of carriage 
found in this study. First, the chronic carriage prevalence may be low and asymptomatic 
may not make any major contribution to on-going transmission in the community. Second, 
S. Typhi are excreted in feces in low numbers and intermittently, which makes the detection 
of carriers difficult, and thus true prevalence may have been missed. Third, anti-Vi-IgG may 
not be the most appropriate biomarker for serological identification of chronic carriers in 
endemic settings. However, measurement of anti-Vi-IgG is widely considered as potentially 
useful approach for detecting chronic carriers since increased levels of anti-Vi-IgG are highly 
prevalent in apparently healthy individuals of typhoid endemic areas [14]. Therefore, we 
decided to use this biomarker to increase the probability in detecting stool shedding in 
asymptomatic carriers in this setting. Its use is also recommended for investigating the 
outbreaks in non-endemic settings [15].   
The study finding highlights that a) acute cases are the highest risk of shedding and 
therefore transmission (even in pre-symptomatic stages), b) use of anti-Vi-IgG is not helpful 
c) putting resources into finding cases within households has a low pickup rate and so 
should be considered carefully in terms of prioritization. 
In conclusion, it is noteworthy accurate diagnosis and appropriate treatment of acute 
typhoid patients as well as short-term convalescent carriers are urgently needed to prevent 
the outbreaks and to eliminate typhoid fever from endemic countries.  Similarly, better 
approaches are needed for surveillance and population level detection of carriers in 
endemic settings, as vaccine is rolled out and carriage becomes more of an issue/barrier to 
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Table 1:  Isolation of S. Typhi in stool specimens of blood culture and stool culture positive 
patients at different time points 
  
 





SC +ve for 




for culture  
SC +ve for 
S. Typhi  
% of 
isolation 
Day 30 281 15 5 9 1 11 
Day 180 270 1 0.4 9 0 0 
Day 365* 15 0 0 1 0 0 
Abbreviations: BC, blood culture; SC, stool culture 
































































































Table 2: Isolation of S. Typhi in stool specimens of household contacts of blood and stool 
culture positive patients at different time points 
  
 





SC +ve for 






SC +ve for 
S. Typhi  
% of 
isolation 
Day 0 530 5 0.9 9 0 0 
Day 30 466 4 0.7 9 0 0 
Day 180* 7 0 0 0 0 0 
Abbreviations: BC, blood culture; SC, stool culture; HH, household 
*Stool collected on day 180- if stool culture was positive for S. Typhi on day 0 and/or day 30 
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